Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Feb 11;9(4):1929-1932.
doi: 10.1002/ccr3.3906. eCollection 2021 Apr.

Use of the NobleStitch™ EL for the treatment of patients with residual right-to-left shunt following device closure of PFO

Affiliations
Case Reports

Use of the NobleStitch™ EL for the treatment of patients with residual right-to-left shunt following device closure of PFO

Nadia Chaudhry-Waterman et al. Clin Case Rep. .

Abstract

The unique design of the NobleStitch™ EL allows it to be used to close residual defects following failed device PFO closure without impacting the integrity of previously placed double-disk Gore occluders.

Keywords: Heartstitch; cryptogenic stroke; patent foramen ovale; platypnea‐orthodeoxia syndrome; residual shunt.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

FIGURE 1
FIGURE 1
Fluoroscopy during cardiac catheterization shows interatrial communication and residual shunt. Left: Residual shunting demonstrated by contrast‐enhanced fluoroscopy showing contrast crossing over interatrial septum at the superior border of the previously placed double‐disk device. Right: Sizing balloon positioned at the superior border of the previously placed double‐disk device measured a 4 mm residual defect
FIGURE 2
FIGURE 2
Intracardiac echocardiogram (ICE) displays interatrial septum before and after NobleStitch™ EL placement. Left: ICE from case 1 shows positive bubble study, with “snowstorm” appearance of the left atrium indicating the presence of a right‐to‐left shunt. Right: ICE from case 1 shows intact septum following NobleStitch™ EL placement. Negative bubble study performed at the time of this image showed complete resolution of left‐to‐right shunt
FIGURE 3
FIGURE 3
Fluoroscopy during cardiac catheterization shows NobleStitch™ EL needle deployment and blind‐ending tunnel following KwiKnot deployment. Left: Fluoroscopy during case shows needle of the NobleStitch™ EL system capturing the septum secundum. Right: After KwiKnot deployment, contrast‐enhanced fluoroscopy shows blind‐ending tunnel with complete closure

Similar articles

Cited by

References

    1. Abdelghani M, El‐Shedoudy SAO, Nassif M, Bouma BJ, de Winter RJ. Management of patients with patent foramen ovale and cryptogenic stroke: An update. Cardiology. 2019;143(1):62‐72. - PubMed
    1. Matsumura K, Gevorgyan R, Mangels D, Masoomi R, Mojadidi MK, Tobis J. Comparison of residual shunt rates in five devices used to treat patent foramen ovale. Catheter Cardiovasc Interv. 2014;84(3):455‐463. - PubMed
    1. Rana BS, Shapiro LM, McCarthy KP, Ho SY. Three‐dimensional imaging of the atrial septum and patent foramen ovale anatomy: defining the morphological phenotypes of patent foramen ovale. Eur J Echocardiogr. 2010;11(10):i19‐25. - PubMed
    1. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59(1):17‐20. - PubMed
    1. Giblett JP, Abdul‐Samad O, Shapiro LM, Rana BS, Calvert PA. Patent foramen ovale closure in 2019. Intervent Cardiol (London, England). 2019;14(1):34‐41. - PMC - PubMed

Publication types

LinkOut - more resources